| 000 | 01863 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517051311.0 | ||
| 264 | 0 | _c20161025 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-15-0339 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEaton, Anne | |
| 245 | 0 | 0 |
_aToxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cFeb 2016 |
||
| 300 |
_a553-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aNeoplasms _xdiagnosis |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aIasonos, Alexia | |
| 700 | 1 | _aGounder, Mrinal M | |
| 700 | 1 | _aPamer, Erika G | |
| 700 | 1 | _aDrilon, Alexander | |
| 700 | 1 | _aVulih, Diana | |
| 700 | 1 | _aSmith, Gary L | |
| 700 | 1 | _aIvy, S Percy | |
| 700 | 1 | _aSpriggs, David R | |
| 700 | 1 | _aHyman, David M | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 22 _gno. 3 _gp. 553-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-15-0339 _zAvailable from publisher's website |
| 999 |
_c25218869 _d25218869 |
||